Oluwadamilola T Oladeru1,2, Sung Jun Ma3, Joseph A Miccio4, Katy Wang5, Kristopher Attwood5, Anurag K Singh3, Daphne A Haas-Kogan2, Paula M Neira6. 1. Department of Radiation Oncology, University of Florida, Gainesville, FL. 2. Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institution, Boston, MA. 3. Departments of Radiation Medicine. 4. Department of Radiation Oncology, Penn State Milton S. Hershey Medical Center, Camp Hill, PA. 5. Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY. 6. Johns Hopkins Center for Transgender Health, Johns Hopkins Medicine, Baltimore, MD.
Abstract
OBJECTIVES: The population of individuals who identify as transgender (TG) is increasing in the United States, yet disparities in cancer screening services are widening. It is imperative that interpersonal and systemic barriers to cancer care are identified and removed for this vulnerable population. Our study sought to examine the difference in self-reported breast and cervical cancer screening rates between TG and cisgender (CG) people. MATERIALS AND METHODS: Cross-sectional data from the 2014 to 2016 and 2018 Behavioral Risk Factor Surveillance System (BRFSS) was obtained on individuals who identified as CG or TG (male-to-female [MTF] and female-to-male [FTM]), including their responses to questions regarding breast and cervical screening history and their primary care access and associated barriers. RESULTS: Compared with the CG population, TG participants were less likely to adhere to or have undergone breast (FTM: odds ratio [OR] 0.47 and 0.32; MTF: OR 0.04 and 0.02, respectively; all P<0.001) and cervical cancer (FTM: OR 0.42 and 0.26, respectively; all P<0.001) screening. They were also less likely to have a primary care physician (FTM: OR 0.79; MTF: OR 0.58; all P<0.001) and less likely to seek primary care within a year owing to medical costs (FTM: OR 1.44; MTF: OR 1.36; all P<0.001). CONCLUSIONS: Disparities exist in the uptake of routine cancer screening in the TG population despite their increased risk for breast and cervical cancer. Interventions are urgently needed to mitigate delays to cancer screening, close gaps in provider and patient knowledge about cancer screening, and improve health care experiences of gender minorities in the United States.
OBJECTIVES: The population of individuals who identify as transgender (TG) is increasing in the United States, yet disparities in cancer screening services are widening. It is imperative that interpersonal and systemic barriers to cancer care are identified and removed for this vulnerable population. Our study sought to examine the difference in self-reported breast and cervical cancer screening rates between TG and cisgender (CG) people. MATERIALS AND METHODS: Cross-sectional data from the 2014 to 2016 and 2018 Behavioral Risk Factor Surveillance System (BRFSS) was obtained on individuals who identified as CG or TG (male-to-female [MTF] and female-to-male [FTM]), including their responses to questions regarding breast and cervical screening history and their primary care access and associated barriers. RESULTS: Compared with the CG population, TG participants were less likely to adhere to or have undergone breast (FTM: odds ratio [OR] 0.47 and 0.32; MTF: OR 0.04 and 0.02, respectively; all P<0.001) and cervical cancer (FTM: OR 0.42 and 0.26, respectively; all P<0.001) screening. They were also less likely to have a primary care physician (FTM: OR 0.79; MTF: OR 0.58; all P<0.001) and less likely to seek primary care within a year owing to medical costs (FTM: OR 1.44; MTF: OR 1.36; all P<0.001). CONCLUSIONS: Disparities exist in the uptake of routine cancer screening in the TG population despite their increased risk for breast and cervical cancer. Interventions are urgently needed to mitigate delays to cancer screening, close gaps in provider and patient knowledge about cancer screening, and improve health care experiences of gender minorities in the United States.
Authors: Tara Kiran; Sam Davie; Dhanveer Singh; Sue Hranilovic; Andrew D Pinto; Alex Abramovich; Aisha Lofters Journal: Can Fam Physician Date: 2019-01 Impact factor: 3.275
Authors: Madeline B Deutsch; Jamison Green; JoAnne Keatley; Gal Mayer; Jennifer Hastings; Alexandra M Hall Journal: J Am Med Inform Assoc Date: 2013-04-30 Impact factor: 4.497